Sanofi
ANTIGENIC EPSTEIN BARR VIRUS POLYPEPTIDES
Last updated:
Abstract:
This disclosure relates to antigenic EBV polypeptides and their use in eliciting antibodies against EBV. Also disclosed are antigenic polypeptides comprising an EBV polypeptide and a ferritin protein.
Status:
Application
Type:
Utility
Filling date:
1 Oct 2020
Issue date:
21 Jan 2021